Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)

M Raikou; A McGuire; H M Colhoun; D J Betteridge; P N Durrington; G A Hitman; H A W Neil; S J Livingstone; V Charlton-Menys; J H Fuller; CARDS Investigators

doi:10.1007/s00125-006-0561-4

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)

M Raikou, A McGuire, H M Colhoun, D J Betteridge, P N Durrington, G A Hitman, H A W Neil, S J Livingstone, V Charlton-Menys, J H Fuller, CARDS Investigators

Research output: Contribution to journal › Article › peer-review

33 Citations (Scopus)

Abstract

We estimated the cost-effectiveness of atorvastatin treatment in the primary prevention of cardiovascular disease in patients with type 2 diabetes using data from the Collaborative Atorvastatin Diabetes Study (CARDS).

Original language	English
Pages (from-to)	733-740
Number of pages	8
Journal	Diabetologia
Volume	50
Issue number	4
DOIs	https://doi.org/10.1007/s00125-006-0561-4
Publication status	Published - 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00125-006-0561-4

Cite this

Raikou, M., McGuire, A., Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., Neil, H. A. W., Livingstone, S. J., Charlton-Menys, V., Fuller, J. H., & CARDS Investigators (2007). Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS). Diabetologia, 50(4), 733-740. https://doi.org/10.1007/s00125-006-0561-4

@article{83d76f38de50476899eba384c0c67bd1,

title = "Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)",

abstract = "We estimated the cost-effectiveness of atorvastatin treatment in the primary prevention of cardiovascular disease in patients with type 2 diabetes using data from the Collaborative Atorvastatin Diabetes Study (CARDS).",

author = "M Raikou and A McGuire and Colhoun, {H M} and Betteridge, {D J} and Durrington, {P N} and Hitman, {G A} and Neil, {H A W} and Livingstone, {S J} and V Charlton-Menys and Fuller, {J H} and {CARDS Investigators}",

year = "2007",

doi = "10.1007/s00125-006-0561-4",

language = "English",

volume = "50",

pages = "733--740",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "4",

}

Raikou, M, McGuire, A, Colhoun, HM, Betteridge, DJ, Durrington, PN, Hitman, GA, Neil, HAW, Livingstone, SJ, Charlton-Menys, V, Fuller, JH & CARDS Investigators 2007, 'Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)', Diabetologia, vol. 50, no. 4, pp. 733-740. https://doi.org/10.1007/s00125-006-0561-4

TY - JOUR

T1 - Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes

T2 - results from the Collaborative Atorvastatin Diabetes Study (CARDS)

AU - Raikou, M

AU - McGuire, A

AU - Colhoun, H M

AU - Betteridge, D J

AU - Durrington, P N

AU - Hitman, G A

AU - Neil, H A W

AU - Livingstone, S J

AU - Charlton-Menys, V

AU - Fuller, J H

AU - CARDS Investigators

PY - 2007

Y1 - 2007

N2 - We estimated the cost-effectiveness of atorvastatin treatment in the primary prevention of cardiovascular disease in patients with type 2 diabetes using data from the Collaborative Atorvastatin Diabetes Study (CARDS).

AB - We estimated the cost-effectiveness of atorvastatin treatment in the primary prevention of cardiovascular disease in patients with type 2 diabetes using data from the Collaborative Atorvastatin Diabetes Study (CARDS).

U2 - 10.1007/s00125-006-0561-4

DO - 10.1007/s00125-006-0561-4

M3 - Article

C2 - 17265034

SN - 0012-186X

VL - 50

SP - 733

EP - 740

JO - Diabetologia

JF - Diabetologia

IS - 4

ER -

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this